New Edge Advisors, LLC Volitionrx LTD Transaction History

New Edge Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.69 - $1.53 $345 - $765	-500 Reduced 71.43%	200 $0
Q2 2023 Aug 14, 2023	SELL	$1.39 - $2.02 $152 - $222	-110 Reduced 13.58%	700 $0
Q4 2022 Feb 14, 2023	BUY	$1.39 - $2.6 $1,125 - $2,106	810 New	810 $1,000
Q3 2021 Oct 29, 2021	SELL	$2.98 - $3.48 $45,075 - $52,638	-15,126 Closed	0 $0
Q2 2021 Jul 22, 2021	SELL	$3.01 - $3.78 $5,625 - $7,064	-1,869 Reduced 11.0%	15,126 $50,000
Q1 2021 Apr 26, 2021	BUY	$3.33 - $6.5 $56,593 - $110,467	16,995 New	16,995 $64,000

17.8M

41K

100

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $45.3M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on New Edge Advisors, LLC with notifications on news.